Pharmaceuticals News and Research

RSS

Modified silicon-based surfaces provide good home to proteins

Silicon, whether in its elemental form as silicon wafers or in its oxidized form, known as silicon dioxide or silica, is proving to be a valuable material for biomedical nanotechnology, in large part because of the biocompatibility and chemical inertness of these substances.

13 Nov 2006

Polymer coating improves tumor-targeting nanoparticles

Adding a thin coating of the biocompatible polymer poly(ethylene glycol) (PEG) to the surface of sulfur-modified, or thiolated, nanoparticles designed to fall apart inside tumors, prolongs the time that the resulting nanoparticles remain in tumors.

13 Nov 2006

Arthritis drugs not as risky as first thought

Researchers now say that two biotech drugs used to treat rheumatoid arthritis, Humira (Abbott Laboratories) and Remicade (Johnson & Johnson), may not raise the risk of cancer and infections as much as was initially feared.

8 Nov 2006

WHO to tackle counterfeit medical products

On 15 November, the World Health Organization (WHO) and its partners will officially launch the first ever International Medical Products Anti-counterfeiting Taskforce (IMPACT) and unveil the global plan to combat counterfeit medical products.

6 Nov 2006

Cancer Research Technology to present discovery updates at BioEurope 2006

Cancer Research Technology Limited (CRT), the oncology-focused development and commercialisation company, today announce that Phil L'Huillier, the Director of Business Management, will present at the BioEurope 2006 Annual International Partnering Conference.

6 Nov 2006

Compound in red wine counters effects of a high-calorie diet

The results of an international study suggests that a compound found in red wine gave mice longer and healthier lives and also countered some of the effects of a high-calorie diet.

1 Nov 2006

Mini artificial liver grown from stem cells

Scientists in Britain have grown the first artificial liver from stem cells, which is the first step in a process which within 10 years could see livers being grown in a laboratory for human transplants.

1 Nov 2006

Spanish patent victory favoring Ranbaxy on Atorvastatin unaffected

Ranbaxy Laboratories Limited said today that recently, in two separate rulings, the Spanish courts (the Mercantile Court of Barcelona, No. 2) found Spanish patent ES 2,167,306 (counterpart of Pfizer's EP 409 281) to be invalid for lack of novelty.

30 Oct 2006

Turmeric for prevention of rheumatoid arthritis and osteoporosis

An ancient spice, long used in traditional Asian medicine, may hold promise for the prevention of both rheumatoid arthritis and osteoporosis, according to a recently completed study at The University of Arizona College of Medicine.

30 Oct 2006

New initiative to combat corruption in medicines procurement

Huge amounts of money - up to $50 billion - are spent every year on pharmaceutical products, a market so large that it is extremely vulnerable to corruption. Recent estimates have shown that as much as 25% of medicines which are procured can be lost to fraud, bribery and other corrupt practices.

30 Oct 2006

Big pharma contributes millions to Republican congressional campaigns in close races

The Wall Street Journal on Wednesday examined how pharmaceutical companies are "pouring millions of dollars" into congressional campaigns in close races, "giving some Republicans a financial edge."

26 Oct 2006

Scientists step toward next generation of cancer-beating drugs

Scientists helping to develop the next generation of cancer-beating drugs say they have had a major breakthrough with their latest results.

From The University of Manchester 26 Oct 2006

WHO unveils new strategy to fight some of the most neglected tropical diseases

The World Health Organization (WHO) and a group of more than 25 partner organizations unveiled a new strategy to fight some of the most neglected tropical diseases that destroy the lives and health of poor people.

26 Oct 2006

PBM Medco Health Solutions agrees to settle Medicare fraud, kickback allegations for $155 million

Medco Health Solutions, the largest U.S. pharmacy benefit manager, on Monday agreed to pay $155 million to settle fraud allegations brought by the federal government and several former company employees, the Newark Star-Ledger reports (Silverman, Newark Star-Ledger, 10/24).

24 Oct 2006

Flu vaccinations in Israel back on

According to Israeli health officials the deaths of four men who had received a flu jab were not connected to the vaccination and the flu vaccination programme will now be resumed.

23 Oct 2006

Democrats should 'stand up strongly' for principles, columnist writes

If the Democrats gain control of at least one chamber of Congress, "the best thing that [they] can do, not just for their party and their country, but for the cause of bipartisanship, is ... stand up strongly for their principles," columnist Paul Krugman writes in a New York Times opinion piece.

23 Oct 2006

Washington, D.C., to offer caremark Rx discount cards to all residents

Washington, D.C., Mayor Anthony Williams on Wednesday announced a program called DC Rx that will provide prescription drug discount cards at no cost to residents, the Washington Post reports (Silverman, Washington Post, 10/19).

22 Oct 2006

Columnist explores reasons for discrepancy in U.S., foreign health spending, related life expectancies

The answer to why many countries spend less on health care than the U.S. and have higher life expectancies is "fantastically complicated -- but also fantastically important," New York Times columnist David Leonhardt writes.

19 Oct 2006

Antiretroviral drug discounts should be extended for countries classified as 'middle-income'

Pricing antiretroviral drugs and other "lifesaving" medications based on a country's gross national income per capita "seems particularly arbitrary -- and even cruel" -- given that HIV-positive people often have incomes "well below what might be considered a country's 'average' income," Jorge Saavedra Lopez.

19 Oct 2006

Toxic chemical found in 3 more medicines in Panama

A toxic chemical found in contaminated cough syrup suspected to have caused the deaths of 22 people in Panama, has now been found in three more medications made by a government-run factory in Panama.

19 Oct 2006